<DOC>
	<DOC>NCT01057628</DOC>
	<brief_summary>This study is to compare the efficacy and safety of ASP1941 with placebo in Japanese patients with type 2 diabetes mellitus.</brief_summary>
	<brief_title>A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Type 2 diabetic patients for at least 12 weeks HbA1c value between 7.0 and 10.0% Body Mass Index (BMI) 20.0 45.0 kg/m2 Investigator adjudicates that a subject is able to discontinue currently taking hypoglycemic agents safely during treatment Type 1 diabetes mellitus patients Serum creatinine &gt; upper limit of normal Proteinuria (albumin/creatinine ratio &gt; 300mg/g) Dysuria and/or urinary tract infection, genital infection Significant renal, hepatic or cardiovascular diseases Severe gastrointestinal diseases</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>ASP1941</keyword>
	<keyword>Diabetes mellitus</keyword>
	<keyword>Blood glucose</keyword>
</DOC>